Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biophysical Journal|July 25, 2012
Role of elongation and secondary pathways in S6 amyloid fibril growthNikolai Lorenzen, Samuel I A Cohen, Søren B Nielsen, et al.
Molecular Pharmaceutics|September 26, 2025
Bayesian Optimization for Efficient Multiobjective Formulation Development of BiologicsIsabel Waibel, Timo N Schneider, Fiona J Fischer, et al.
Biophysical Chemistry|November 20, 2016
Antibodies against the C-terminus of α-synuclein modulate its fibrillationCagla Sahin, Nikolai Lorenzen, Lasse Lemminger, et al.
Molecular Pharmaceutics|September 14, 2021
Design of Biopharmaceutical Formulations Accelerated by Machine LearningHarini Narayanan, Fabian Dingfelder, Itzel Condado Morales, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2023
Surface patches induce nonspecific binding and phase separation of antibodiesHannes Ausserwöger, Georg Krainer, Timothy J Welsh, et al.
Analytical Chemistry|March 17, 2023
Multidimensional Protein Solubility Optimization with an Ultrahigh-Throughput Microfluidic PlatformNadia A Erkamp, Marc Oeller, Tomas Sneideris, et al.
Mabs|December 8, 2018
In vitro and in silico assessment of the developability of a designed monoclonal antibody libraryAdriana-Michelle Wolf Pérez, Pietro Sormanni, Jonathan Sonne Andersen, et al.
The Journal of Biological Chemistry|June 8, 2014
How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitroNikolai Lorenzen, Søren B Nielsen, Yuichi Yoshimura, et al.
Communications Chemistry|May 12, 2026
Molecular origins of opalescence and phase separation in mAb formulations and their relation to aggregationInna Brakti, Samuel Lenton, Marco Polimeni, et al.
Biochemistry|May 24, 2019
Improving the Developability of an Antigen Binding Fragment by Aspartate SubstitutionsLaila I Sakhnini, Per J Greisen, Charlotte Wiberg, et al.
Pageof 4